| Date | Title | Description |
| 21.05.2025 | Zydus bets big on vaccines and medtech | - |
| 18.04.2025 | Feldan Therapeutics: Investment Raised From Zynext Ventures | Zynext Ventures, the VC arm of Zydus Lifesciences, announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage pharmaceutical company pioneering the development of treatments based on intracellular delivery... |
| 13.04.2025 | Drug makers Glenmark, Sun Pharma, Zydus recall products in US | - |
| 15.03.2025 | Indian Pharma's Bold Leap into the U.S. Market: A New Era of Acquisitions | The Indian pharmaceutical industry is on the move. Like a ship navigating through stormy seas, companies are expanding their reach into the U.S. market. This surge in acquisitions is not just a trend; it’s a strategic response to shifting t... |
| 14.03.2025 | Indian pharma ramps up US acquisitions amid regulatory and market shifts | Indian pharmaceutical companies are aggressively expanding their US presence through a wave of acquisitions, likely as a hedge against future uncertainties. Leading players like Sun Pharma, Syngene, Senores, and Zydus have all made strategi... |
| 17.10.2024 | Burkert inaugurates manufacturing facility in Pune, aims to strengthen portfolio in India | Burkert Fluid Control Systems India Private Limited, a prominent manufacturer of measurement and control systems for liquids and gases, has inaugurated its new manufacturing facility in Pune, Maharashtra, with a grand ceremony. This state-o... |
| 17.08.2024 | ICICI Lombard's Bancassurance Expansion: A Strategic Leap into the Future | In a bold move, ICICI Lombard General Insurance has forged partnerships with seven financial institutions, aiming to broaden its bancassurance network. This strategic initiative is more than just a business expansion; it’s a lifeline for mi... |
| 14.08.2024 | Vodafone Idea, Oil India, and 5 others to join MSCI India Index
CONCOR Plans Strategy for GCT Scheme Risks
IndiGo Targets 1,000 Women Pilots in Year
Delhi Airport's New Terminal 1 Expansion Opens | ECONOMY & POLICY Vodafone Idea, Oil India, and 5 others to join MSCI India Index
14 Aug 2024 2 Min Read CW Team
According to the latest index review by MSCI, seven firms, including Vodafone Idea and Oil India, are set to be added to the... |
| 29.05.2024 | Health secy highlights India's achievements, future goals at WHO assembly | - |
| 25.05.2024 | Kasturba Medical College, Mangalore Celebrates 70th Anniversary with a Grand College Day and Awards Ceremony | Manipal, Karnataka, India
Kasturba Medical College (KMC), Mangalore, a constituent unit of Manipal Academy of Higher Education (MAHE), Manipal, commemorated College Day and Awards Ceremony on Friday, 24 May, at Dr T M A Pai International Co... |
| 17.05.2024 | Indian pharma firms supplied 47% of all generic prescriptions in US in 2022 | - |
| 08.05.2024 | Dr Reddy's Labs slumps 5% as brokerages give 'Reduce' call post Q4 earnings | - |
| 04.05.2024 | Productivity loss due to oral cancer in India in 2022 at $5.6 bn: Study | - |
| 03.05.2024 | Delhi HC directs action against use of oxytocin in dairy colonies | - |
| 02.05.2024 | India, New Zealand look to boost collaboration in pharma, digital trade | - |
| 01.05.2024 | Mizoram sees alarming surge in TB deaths, 108 succumb to disease in 2023 | - |
| 09.04.2024 | Best of BS Opinion: Buybacks' importance, productive employment, more | Return on capital and return on liquor policy are what we have today
Share buyback is a good way for companies to reward their shareholders, says Akash Prakash
Click here to follow our WhatsApp channel
Gurbachan Singh lays bare the changes ... |
| 21.01.2022 | Cadila Healthcare : Zydus receives final approval from USFDA for Vigabatrin Tablets | www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
fd560c3d60edb319e469a3a97a444a25... |
| 22.12.2021 | Cadila Healthcare : Zydus Cadila receives tentative approval from USFDA for Pimavanserin Tablets | Zydus Cadila receives tentative approval from USFDA for
Pimavanserin Tablets
Ahmedabad, 22 December, 2021
Zydus Cadila has received tentative approval from the USFDA to market Pimavanserin Tablets, 10 mg (US RLD: Nuplazid Tablets). Pimavans... |
| 16.12.2021 | Cadila Healthcare : Zydus receives Orphan Drug Designation from US FDA for ZY-19489, a novel compound to treat malaria | Zydus receives Orphan Drug Designation from US FDA for
ZY-19489, a novel compound to treat malaria
ZY19489 is a novel anti-malarial compound active against all current clinical strains of P. falciparum and P. vivax, including drug resistant... |
| 10.12.2021 | Cadila Healthcare : Zydus announces EPICS-IIITM Phase 2(b)/3 adaptive pivotal clinical trial of Saroglitazar Mg in PBC | www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
84eacba4925d0e70d060327c9369023b... |
| 18.11.2021 | Cadila Healthcare : Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA | www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
7b6c401d4a92eeb62dcf1d26bc03e483... |
| 10.11.2021 | Zydus Cadila receives final approval from USFDA for Glycopyrrolate Injection | Zydus Cadila receives final approval from USFDA for
Glycopyrrolate Injection
Ahmedabad, India, 10 November, 2021
Zydus Cadila has received final approval from the USFDA to market Glycopyrrolate Injection in the strengths of 0.2 mg/mL and 0.... |
| 22.10.2021 | Cadila Healthcare : Zydus announces ‘first patient' randomised in EVIDENCES-X TM Phase II(b) clinical trial of Saroglitazar Mg in NASH | www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
8946b0739bb182bd1a59ff3123401467... |
| 08.10.2021 | Cadila Healthcare : Zydus Cadila receives tentative approval from USFDA for Adapalene and Benzoyl Peroxide Gel | www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
58c06b242a669cab80ce1a6ac5e80d3c... |
| 06.10.2021 | Cadila Healthcare's New Covid-19 Vaccine Gives Booster Shot To Company Chairman's Wealth | Pankaj Patel, Chairman, Cadila Healthcare Mayur D Bhatt/ Forbes India |
| 24.09.2021 | Cadila Healthcare : Zydus Cadila receives final approval from USFDA for Apremilast Tablets | Zydus Cadila receives final approval from USFDA for
Apremilast Tablets
Ahmedabad, India, 24 September, 2021
Zydus Cadila's U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received final approval from the USFDA to market Apremilast Tabl... |
| 29.08.2021 | India’s Covid-19 Vaccination Drive Gathers Speed As More Jabs Gain Approval | Pankaj Patel takes part in a business dialogue titled "Russia-India: Identifying New Opportunities" ... [+] as part of the 2017 Eastern Economic Forum at Far Eastern Federal University on Russky Island. Artyom Korotayev\TASS via G... |
| 13.08.2021 | Cadila Healthcare : Zydus Cadila receives final approval from USFDA for Mesalamine Extended-Release Capsules | www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
3821961251014802199a9c1b2434d942... |
| 21.07.2021 | Animal health companies can do more to fight antibiotic resistance, says FAIRR | In the ongoing discussion around the world’s growing antibiotic resistance problem, animal agriculture and its high use of antibiotics has been one of the primary issues. Meat companies have responded by launching new policies and protocols... |
| 21.07.2021 | Cadila Healthcare : Zydus Cadila receives tentative approval from the USFDA for Ibrutinib Tablets | www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
620917f4067bd04eb05e9d7fb13e727e... |
| 17.07.2021 | Cadila Healthcare : Annual Report (2020-2021) | Cadila Healthcare Ltd.
I N N O V AT I O N T H AT S A V E S L I V E S
AnnualReport2020-21
CORPORATE INFORMATION
Founder
Late Ramanbhai B. Patel
Board of Directors
Pankaj R. Patel
Chairman
Dr. Sharvil P. Patel
Managing Director
Ganesh N. Naya... |
| 02.07.2021 | Sartorius buys majority stake in German manufacturing player; Cerevel Therapeutics ends the week on a high note, with $350M raise | Sartorius Stedim Biotech acquired a majority stake in Germany-based CellGenix GmbH, the companies announced Friday.
Sartorius has acquired 51% of the company for $118.3 million and announced the plan to acquire the re... |
| 02.07.2021 | Covid-19 roundup: Zydus Cadila submits 3-dose vaccine for regulatory approval; US donates Moderna jabs to Pakistan during shortage | India’s second home-grown vaccine could be approved by regulators soon as Zydus Cadila announced Thursday it has applied for emergency use approval with regulators in that nation.
The jab has demonstrated efficacy of ... |
| 02.07.2021 | A gene therapy to restore damaged tissue after a heart attack clears pigs | When GlaxoSmithKline R&D chief Hal Barron outlined his vision for the new GSK, he touted repeatedly how, digging through functional genomic datasets from partners like 23andMe and the UK Biobank, his team could see things that others ca... |
| 02.07.2021 | Busy IPO week winds down as two more biotechs — and one looking to improve clinical trials — file for public debuts | Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
Two more biotech companies — and one that’s committed to supporting clinical research — filed for IPOs jus... |
| 02.07.2021 | CureVac gains COO and hands Florian von der Mülbe new assignment in the midst of Covid-19 vaccine troubles; As Ken Frazier retires, Merck hires chief strategy officer | Malte Greune
→ Aiming to bounce back and trying to accentuate the positive after its mRNA Covid-19 vaccine took a major pratfall, CureVac is shaking things up by bringing in Malte Greune as COO and giving new responsibi... |
| 01.07.2021 | Covid-19 manufacturing roundup: India starts manufacturing of Novavax vaccine — report; US ships spare shots to Colombia | As India’s second wave of Covid-19 infections continues to trend downward and scientists warn of a third wave of the pandemic that could lead to between 200,000 and 500,000 new cases a day, the Serum Institute of India (SII)... |
| 24.06.2021 | Cadila Healthcare : Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg | zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.
Reference ID IP Address Date and Time
db653615c2cf3d048ea9eddf695e1de9 15.... |
| 28.05.2021 | CADILA HEALTHCARE LIMITED
Cadila Healthcare : Zydus' new tech enabled initiative to safeguard patients against counterfeit drugs | Zydus' new tech enabled initiative to safeguard patients
against counterfeit drugs
Ahmedabad, India, May 28, 2021
Zydus Cadila, an innovation-driven pharmaceutical company announced that it has introduced a new feature in the packaging of i... |
| 24.05.2021 | CADILA HEALTHCARE LIMITED
Cadila Healthcare : Zydus Launches Ujvira (Trastuzumab Emtansine), a Breakthrough in Breast Cancer Treatment | Zydus launches Ujvira (Trastuzumab Emtansine), a breakthrough in Breast Cancer treatment
Launch marks the World's first biosimilar Antibody Drug Conjugate of Trastuzumab
Emtansine.
The therapy will be priced at nearly 80% less than the curr... |
| 12.05.2021 | Cadila Healthcare : SE Intimation Pearl | __________________________________________________________________________________
May 12, 2021
Listing Department Code: 532 321
BSE LIMITED P J Towers, Dalal Street, Fort, Mumbai-400 001 Listing Department Code: CADILAHC
NATIONAL STOCK EXC... |
| 23.04.2021 | CADILA HEALTHCARE LIMITED
Cadila Healthcare : Zydus receives Emergency Use Approval from DCGI for the use of Pegylated Interferon alpha-2b, ‘Virafin' in treating moderate COVID-19 infection in adults... | Zydus receives Emergency Use Approval from DCGI for the use of Pegylated Interferon alpha-2b, 'Virafin' in treating moderate COVID-19 infection in adults
A single dose of the antiviral Virafin administered subcutaneously early on shows sign... |
| 23.04.2021 | CADILA HEALTHCARE LIMITED
Cadila Healthcare : Zydus Cadila receives final approval from USFDA for Propafenone Hydrochloride Extended Release Capsules | Zydus Cadila receives final approval from USFDA for
Propafenone Hydrochloride Extended-Release Capsules
Ahmedabad, 23 April, 2021
Zydus Cadila has received final approval from the USFDA to market Propafenone Hydrochloride Extended- Release ... |
| 08.04.2021 | CADILA HEALTHCARE LIMITED
Cadila Healthcare : Zydus Cadila receives final approval from the USFDA for Ibrutinib Capsules | Zydus Cadila announces USFDA approval for First Generic for
Ibrutinib Capsules, 70 mg and gets eligibility for 180-day exclusivity
Ahmedabad, 08 April, 2021
Zydus Cadila has received final approval from the USFDA to market Ibrutinib Capsule... |
| 08.04.2021 | CADILA HEALTHCARE LIMITED
Cadila Healthcare : Zydus Cadila announces USFDA approval for First Generic for Ibrutinib Capsules, 70 mg and gets eligibility for 180-day exclusivity | Zydus Cadila announces final USFDA approval for Macitentan Tablets, 10 mg
and gets eligibility for 180-day shared exclusivity
Ahmedabad, 08 April, 2021
Zydus Cadila has received final approval from the USFDA to market Macitentan Tablets, 10... |
| 25.03.2021 | CADILA HEALTHCARE LIMITED
Cadila Healthcare : Zydus Cadila receives tentative approval from the USFDA for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | Zydus Cadila receives tentative approval from the USFDA for
Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
Ahmedabad, 25 March, 2021
Zydus Cadila has received tentative approval from the USFDA to market Emtricitabine and Tenofovir ... |
| 16.04.2020 | Covid-19 vaccine tracker updated to include GSK/Sanofi collaboration | By Jeff Craven
Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the virus that causes Covid-19. The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes... |
| 09.04.2020 | Covid-19 Tracker updates vaccine candidates | By Jeff Craven
On March 11, the World Health Organization classified the Covid-19 outbreak as a pandemic. The disease has reached nearly every country, infecting hundreds of thousands of people and killing thousands.
Curr... |
| 06.01.2016 | FDA slams another Indian drug maker for serious quality problems | If there is a surefire way to arouse the concerns of Food and Drug Administration inspectors, try this: take a notebook listing manufacturing problems, place it in plastic bags along with other paperwork, and toss them in a nearby scrap yar... |
| - | A second coronavirus vaccine developed in India is set to enter phase three clinical trial 'very, very soon' | Cadila Healthcare, also known as Zydus Cadila, is about to start a phase three clinical trial for a potential coronavirus vaccine on roughly 30,000 volunteers, chairman Pankaj Patel told CNBC.
The study, which is expected to begin soon, wil... |
